Last updated on November 2018

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

Brief description of study

The purpose of this study is to evaluate the safety and efficacy of a study drug that targets an abnormal protein in the brain found in people with Alzheimer's Disease (AD).

Clinical Study Identifier: NCT03518073

Contact Investigators or Research Sites near you

Start Over

Jennifer Ingram

Kawartha Regional Memory Clinic
Peterborough, ON Canada
  Connect »